Directed by N.M.K. Ng Ying Kin, PhD, the laboratory measures putative biological markers for various psychiatric conditions and treatment-resistance to usual medications.

By exploring the history of psychiatry, by being informed about the current challenges and by studying future prospects in psychiatry and neuroscience, participants have learnt to distinguish between the myths and realities surrounding mental illne

Directed by J. Bruno Debruille, MD, PhD, the laboratory attempts to discover the neurocognitive mechanisms of psychotic symptoms of schizophrenia, such as delusions, hallucinations, and alienation.

Apart from the drugs, some other therapies have proved successful to slow the onset of Alzheimer's symptoms.

The Eating Disorders Program,  a leader in finding effective treatments, celebrates its 25th anniversary this year.

Ng Ying Kin uses neurochemical analyses to identify peripheral biological markers for various psychiatric disorders.

Judes Poirier who had discovered a novel genetic risk factor that triggers the common form of Alzheimer’s disease, again made history in June.  

Has the use of medication in psychiatry gone too far? A 2008 lecture by Ridha Joober (in French)

A vaccine-based approach could be an effective therapy for people with mild or moderate form of Alzheimer's disease.

Revolutionizing Douglas Medication Distribution System.